Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in April 2026 (Volume 30, Issue 1) Submit manuscript

Gonadotropic pituitary adenomas: Two cases report

Breadcrumb

  • Home
  • Gonadotropic pituitary adenomas: Two cases report

CAMARA M’BALLOU *, MENNANI FATIMA EZZAHRA, RAFI SANA, El MGHARI GHIZLANE and El ANSARI NAWAL

Department of Endocrinology, Diabetology and Metabolic Diseases, PCIM Laboratory, FMPM, Cadi Ayyad University, CHU Mohamed VI Marrakech, Morocco.
 
Case Study
World Journal of Advanced Research and Reviews, 2023, 17(02), 732-734
Article DOI: 10.30574/wjarr.2023.17.2.0297
DOI url: https://doi.org/10.30574/wjarr.2023.17.2.0297
 
Received on 08 January 2023; revised on 19 February 2023; accepted on 22 February 2023
 
The pituitary gonadotropic adenoma is an adenoma developed́ in the gonadotropic cells of the anterior pituitary. It can be secreting releasing in excess in blood and urine; the products of its secretion are gonadostimulines (F.S.H. and L.H.) or non-secreting in this case only histo- cytochemical analysis will be able to allow identification. We report two cases of macroadenoma with LH-FSH immunostaining. Pituitary magnetic resonance imaging revealed a macroadenoma. Transphenoidal surgery was incomplete. Immunohistochemical staining showed that the tumor cells were reactive to LH (70%) and FSH (30%). Control pituitary imaging revealed a residual macroadenoma and deficit replacement was started.
Hormonal testing for all patients with pituitary adenoma should be performed even in the absence of symptoms of hypersecretion. The treatment of gonadotropic adenomas is surgical. Complementary radiotherapy is usually indicated in case of postoperative tumor remnants with an effect on the prevention of recurrence. Medical treatment (dopaminergic agonists, somatostatin analogues, GnRH agonists and antagonists) is disappointing.
 
Adénome gonadotrope; Immuno-cytochimie; Folliculostimulating hormone (FSH); Luteining hormone (LH)
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2023-0297.pdf

Preview Article PDF

CAMARA M’BALLOU, MENNANI FATIMA EZZAHRA, RAFI SANA, El MGHARI GHIZLANE and El ANSARI NAWAL. Gonadotropic pituitary adenomas: Two cases report. World Journal of Advanced Research and Reviews, 2023, 17(2), 732-734. Article DOI: https://doi.org/10.30574/wjarr.2023.17.2.0297

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution